JP Morgan Chase’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
JP Morgan Chase's BNTX Position: Q1 2026 in Review
JP Morgan Chase increased its BioNTech (BNTX) stake by 4.1% in Q1 2026, buying an estimated $470K and bringing the position to 117,268 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.
JP Morgan Chase first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.7M in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.
- JP Morgan Chase held 117,268 shares of BioNTech worth $10M as of Q1 2026.
- JP Morgan Chase bought 4,571 BioNTech shares in Q1 2026, an estimated $470K.
- BioNTech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2670 holding.
- JP Morgan Chase first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
- JP Morgan Chase's BioNTech position peaked at $10.7M in Q4 2025.
- 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.